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ABSTRACT
Objective: To study the association between
socioeconomic deprivation and prevalence of diabetic
retinopathy (DR).
Design: Population-based, cross-sectional
observational study and retrospective longitudinal
analysis over 12 years.
Setting: Primary care, East of Scotland.
Methods: Outcome data from DR screening
examinations (digital retinal photography) were
collected from the Scottish regional diabetes electronic
record from inception of database to December 2012.
The overall Scottish Index of Multiple Deprivation
(SIMD) 2012 score for each patient was obtained using
their residential postcode. Multiple binary logistic
regression was used to analyse the relationship between
overall SIMD score and prevalence of DR, adjusting for
other variables: age, gender, glycated haemoglobin,
cholesterol levels and duration of disease.
Primary outcome: Any retinopathy (R1 and above) in
either eye.
Results: A total of 1861 patients with type 1 diabetes
mellitus (DM) and 18 197 patients with type 2 DM were
included in the study. Prevalence of DR in type 1 and
type 2 DM were 56.3% and 25.5%, respectively.
Increased prevalence of DR in type 1 DM was
associated with higher overall SIMD score (p=0.002),
with an OR for the most deprived relative to the least
deprived of 2.40 (95% CI 1.36 to 4.27). In type 2 DM,
the overall SIMD score was not significantly associated
with increased prevalence of DR, with an OR for the
most deprived relative to the least deprived of 0.85
(95% CI 0.71 to 1.02, p=0.07).
Conclusions: Socioeconomic deprivation is associated
with increased prevalence of DR in patients with type 1
DM and this occurs earlier. This highlights the need for
targeted interventions to address inequalities in eye
healthcare.
INTRODUCTION
Despite well-established national diabetes
screening programmes, diabetic retinopathy
(DR) and maculopathy remain major causes
of visual impairment among the working-age
population in the UK.1 Early detection
through screening and prompt treatment
may prevent progression to blindness,2 3
thereby, justifying the provision of an equal
and free-access retinopathy screening pro-
gramme for all patients with diabetes mellitus
(DM). In the year 2011/2012, an estimated
£2.6 million was spent on DR screening in the
UK.4 Undoubtedly, the high expenditure
involved in running these screening pro-
grammes raises questions as to whether this is
a wise investment and if inequalities truly exist
in a free-access healthcare system such as the
National Health Service (NHS).5
Previous large epidemiological studies evalu-
ating the incidence of DR in patients with a
poor socioeconomic background have been
unable to account for major risk factors in the
development of DR, such as poor glycaemic
control and longer duration of disease, which
may be more prevalent in patients in lower
socioeconomic groups. Moreover, uptake of
the screening programme is especially low
among those living in deprived areas where
access to the nearest eye care provider is
limited.6 7
Strengths and limitations of this study
▪ Large sample size of 20 058 patients.
▪ Longitudinal cohort of patients followed up sys-
tematically using the validated Scottish Diabetic
Retinopathy Screening protocol over 12 years.
▪ We have taken into account other potential con-
founders, such as duration of disease, glycated
haemoglobin levels, cholesterol levels and blood
pressure reading, into our analyses.
▪ Unable to account for mortality bias and time at
risk for these patients.
▪ Unable to attain information on the changes in
postcode of these patients.
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Therefore, we seek to explore the association between
socioeconomic deprivation and prevalence of DR in the
East of Scotland where there is a well-established
Scottish Diabetic Retinopathy Screening programme,
adjusting for the known risk factors of DR: duration of
disease, glycated haemoglobin (HbA1c) levels, blood
pressure (BP) and cholesterol levels.
METHODS
Study population
All patients with DM above the age of 12 years and regis-
tered with a general practice in Tayside were referred to
the Scottish Diabetic Retinopathy Screening Service,
excluding those who were unable to attend screening due
to inﬁrmity and those already attending the hospital oph-
thalmology services. We included all patients with type 1
and type 2 DM who attended DR screening in Tayside
from inception of database until December 2012. For the
longitudinal analysis, we considered only those patients
who received a diagnosis of DM from year 2000 onwards
and did not have retinopathy at time of diagnosis. Patients
were followed up until December 2012.
The Scottish Care Information Diabetes Collaboration system
The Scottish Care Information Diabetes Collaboration
(SCI-DC) data set holds information on the demo-
graphic characteristics of each patient diagnosed with
DM, such as the postcode of residence, registration of
general practitioner (GP), year of birth and date of diag-
nosis of DM. The SCI-DC data set also includes clinical
parameters, which are measured at least once a year
after the diagnosis of diabetes: HbA1c, cholesterol levels,
systolic blood pressure (sBP) and diastolic blood pres-
sure (dBP). We obtained the most recent DR status,
HbA1c, cholesterol, sBP and dBP levels for this study.
Socioeconomic deprivation
We used the Scottish Index of Multiple Deprivation
(SIMD) 2012 score as a measure of area-based depriv-
ation.8 The SIMD score for each geographical data zone
is a combination of 38 indicators of deprivation across
seven broad domains: education, crime, geographic
access, income, skills and training employment, health,
and housing. We used the residential postcodes to assign
each patient an individual SIMD 2012 score. The higher
the SIMD 2012 score, the more deprived the area of resi-
dence. The SIMD score is used to group the data zones
into quintiles: 0–20% most deprived, 20–40%, 40–60%,
60–80%, 80–100% least deprived.
Scottish Diabetic Retinopathy Screening protocol
The protocol for Scottish Diabetic Retinopathy Screening
has been widely published.9 To summarise, all patients
with diabetes in the East of Scotland undergo free annual
DR screening; this is provided by two mobile units
equipped with digital fundus cameras which travel to
every GP practice, and a static camera site in Dundee.6
Grading of DR and maculopathy is performed from
digital retinal photographs and outcomes stored in the
regional screening database linked to the SCI-DC. The
use of digital retinal photographs for DR screening in
Scotland has been previously validated.10 11
The primary outcome of the study was presence of
background DR (R1) or worse, in either eye.
Statistical analyses
Initially, cross-sectional analyses were performed to assess
the relationship between a range of factors and the pres-
ence of DR. This took the form of multivariable binary
logistic regression models, with the dependent variable
indicating whether the most recent screening for each
patient identiﬁed DR (R1 or worse) in either eye. The
SIMD score was included as the covariate, along with a
range of other potentially confounding factors, such as
duration of disease, HbA1c levels, BP and cholesterol
levels. The shape of the relationships between continuous
covariates and the outcome were assessed prior to the ana-
lysis, with log10 transformations applied, where necessary,
to ensure good model ﬁt. In order to test for selection bias
within patients enrolled in the diabetes screening pro-
gramme (SCI-DC database), comparisons were made
between those who did not attend any retinopathy screen-
ing and those who were screened at least once, using the
Mann-Whitney test.
A secondary, longitudinal analysis was then performed,
considering the average time that patients with DM took
to develop retinopathy. As SIMD data were only available
for patients in 2012, we only considered those patients
diagnosed with diabetes from the year 2000 onwards, in
order to minimise the potential for variability over time
in the factors being considered. During the period of
follow-up for each patient, the results of every screening
test were reviewed. The ‘time to event’ was calculated as
the time from diagnosis to the ﬁrst test showing retinop-
athy, with patients being censored at the end of the
period if they did not develop retinopathy. The data
were then analysed using the Kaplan-Meier approach,
with separate curves for each quintile of the SIMD score,
which were compared using log-rank (Mantel-Cox) tests.
In addition to this, a Cox regression model was pro-
duced, which accounted for patients’ age and gender as
additional risk factors.
For all of the analyses, patients with type 1 and type 2
DM were treated separately. All analyses were performed
using IBM SPSS V.19 (IBM Corp. Armonk, New York,
USA). Missing data were excluded on a per-analysis basis
and p<0.05 was deemed to be indicative of statistical
signiﬁcance.
RESULTS
A total of 1861 patients with type 1 DM and 18 197
patients with type 2 DM were included in the study. The
baseline demographic data are summarised in table 1.
Prevalence of DR in type 1 and type 2 DM were 56.3%
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and 25.5%, respectively. There was no statistically signiﬁ-
cant difference in the SIMD scores between the atten-
ders and non-attenders to screening (table 2).
Multivariable analysis (table 3) found strong associa-
tions in both types of DM between the development of
retinopathy and HbA1c level, BP, duration of disease,
gender and cholesterol levels. After accounting for these
effects, increasing SIMD score was found to be asso-
ciated with an increased prevalence of DR in patients
with type 1 DM (OR for a 10 unit increase in score:
1.13, 95% CI 1.04 to 1.22, p=0.002). Since the SIMD
score in our cohort ranges from 2 to 75, this is equiva-
lent to an OR of 2.40 (95% CI 1.36 to 4.27) for patients
from the most deprived areas relative to the least
deprived. This effect was not observed in patients with
type 2 diabetes with the OR for the most deprived rela-
tive to the least deprived being non-signiﬁcant at 0.85
(95% CI 0.71 to 1.02, p=0.074). The multivariable ana-
lysis was also repeated including only the non-modiﬁable
confounding factors (ie, age, gender and disease dur-
ation), which returned comparable results.
The median time from diagnosis of DM to onset of ret-
inopathy (R1) in patients with type 1 DM from the most
deprived areas was 9.1 years as opposed to more than
12 years in all other quintiles (p<0.001; ﬁgure 1). The
10 years retinopathy-free survival for patients with type 1
Table 1 Baseline demographic data
Type of diabetes
Missing (%) Type 1 Type 2
N 1861 18 197
Age* – 40.6 (17.8) 67.1 (12.5)
Sex –
Male 1017 (54.7%) 9896 (54.4%)
Female 844 (45.4%) 8301 (45.6%)
Duration (years)† 0.1 16.4 (7.40, 28.3) 6.52 (2.93, 11.3)
HbA1c† (mmol/mol) 1.2 74.0 (62.0, 87.0) 54.0 (48.0, 65.0)
Cholesterol value (mmol/L)* 1.0 4.58 (1.28) 4.25 (1.05)
Systolic BP (mm Hg)* 0.9 131.0 (16.3) 134.8 (15.7)
Diastolic BP* 0.9 74.4 (10.1) 74.7 (10.1)
Overall SIMD 2012 score† 1.0 14.1 (9.78, 28.0) 14.8 (9.91, 29.0)
Health† −0.18 (−0.58, 0.43) −0.87 (−0.51, 0.50)
Education skills and training† −0.14 (−0.63, 0.54) −0.08 (−0.64, 0.60)
Housing† 15.1 (9.66, 25.2) 15.8 (10.1, 26.4)
Geographic access† 16.3 (7.2, 30.8) 15.0 (6.15, 27.9)
Crime† 260.0 (140.0, 543.0) 284.0 (148.0, 548.0)
Retinopathy 5.6 1733 17 226
No retinopathy 758 (43.7%) 13 184 (76.5%)
With retinopathy 975 (56.3%) 4042 (23.5%)
BDR mild 794 (45.8%) 3656 (21.2%)
BDR observable 63 (3.6%) 208 (1.2%)
BDR referable 54 (3.1%) 104 (0.6%)
Proliferative retinopathy 64 (3.7%) 74 (0.4%)
Maculopathy 8.9 1619 16 667
No maculopathy 1146 (70.8%) 15 479 (92.9%)
With maculopathy 473 (29.2%) 1188 (7.1%)
Observable maculopathy 91 (5.6%) 165 (1.0%)
Referable maculopathy 382 (23.6%) 1023 (6.1%)
*Data presented as mean (SD).
†Data presented as median (25th and 75th quartile).
BDR, background diabetic retinopathy; BP, blood pressure; HbA1c, glycated haemoglobin; SIMD, Scottish Index of Multiple Deprivation.
Table 2 SIMD scores by attendance
Attenders Non-attenders
DM N (%) SIMD N (%) SIMD p Value
Type 1 1720 (93.3%) 14.16 (9.78–28.10) 124 (6.7%) 14.10 (9.79–23.94) 0.665
Type 2 17 081 (94.8%) 14.81 (9.87–29.04) 941 (5.2%) 15.00 (10.04–30.29) 0.101
SIMD data reported as: ‘median (quartiles)’, with p values from Mann-Whitney tests. ‘Non-attenders’ are those that have never been tested for
retinopathy.
DM, diabetes mellitus; SIMD, Scottish Index of Multiple Deprivation.
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DM in the most deprived areas was 40.6% compared with
66.7% for patients from the least deprived areas. A Cox
regression model, accounting for age and gender,
returned a HR of 2.16 (95% CI 1.27 to 3.69) for the most
deprived, relative to the least deprived quintile (p<0.001).
For the remainder of the deprivation quintiles, retinop-
athy hazards were similar. Hence, the increased risk of ret-
inopathy appears to be mainly conﬁned to the 0–20%
most deprived group of patients (table 4).
There was no signiﬁcant difference in the mean time
to retinopathy in patients with type 2 DM from the dif-
ferent SIMD quintiles (p=0.427; ﬁgure 2; table 5).
DISCUSSION
In our study, socioeconomic deprivation was associated
with increased prevalence of DR in patients with type 1
DM, but not in patients with type 2 DM. This was inde-
pendent of the duration of disease, HbA1c value, lipid
proﬁle and BP control. Patients with type 1 DM from a
more deprived background were likely to develop retin-
opathy earlier than those from a less deprived back-
ground. Our ﬁnding of the association between longer
duration of disease, higher HbA1c levels, higher BP,
male gender and increased prevalence of DR is consist-
ent with previous studies.12–14
Strengths and weaknesses of the study
The strengths of our study lie in the large sample size
and longitudinal cohort of patients who have been fol-
lowed up systematically using the validated standardised
yearly Scottish diabetic screening protocol. Through the
integrated electronic patient record system, we were able
to obtain measures of diabetic control, such as HbA1c
levels, BP readings and cholesterol levels.15 However,
one weakness of the study was the use of the most recent
biochemistry and clinical data instead of the overall
mean values. We were unable to attain information on
the changes in postcode of the patients or account for
mortality bias in this study.16 Another limitation to the
study is the inherent bias in using screened populations.
Patients who have not engaged with healthcare services
or the screening programme would not have been
included in the analyses. In addition, some patients
would have presented with severe retinopathy and been
treated under the care of the hospital and hence, were
not included in the screening programme. This could
result in selection bias if factors, such as socioeconomic
deprivation, affect the likelihood of a patient being
screened.
Comparison with other studies
Previous studies have examined the inﬂuences of socio-
economic deprivation on DR in other parts of the UK.
However, these studies did not account for other major
risk factors such as duration of disease, HbA1c levels,
lipid proﬁle and BP control, all of which are known risk
factors for development of DR. In the Gloucestershire
Table 3 Multivariate analysis of factors associated with diabetic retinopathy
Type 1 DM Type 2 DM
OR (95% CI) p Value OR (95% CI) p Value
Gender (male) 1.38 (1.09 to 1.75) 0.006* 1.19 (1.11 to 1.29) <0.001*
Age (decades) 0.92 (0.84 to 0.99) 0.036* 0.90 (0.86 to 0.93) <0.001*
Disease duration (decades) 35.0† (22.5 to 54.5) <0.001* 2.89 (2.72 to 3.07) <0.001*
HbA1c (×10 mmol/mol) 1.17 (1.10 to 1.24) <0.001* 1.12 (1.10 to 1.15) <0.001*
Cholesterol 1.14 (1.01 to 1.29) 0.029* 0.94 (0.90 to 0.97) 0.001*
Systolic BP (×10 mm Hg) 1.03 (0.95 to 1.13) 0.479 1.11 (1.08 to 1.14) <0.001*
Diastolic BP (×10 mm Hg) 1.16 (1.02 to 1.33) 0.024* 0.95 (0.91 to 0.99) 0.028*
Overall SIMD score (×10) 1.13 (1.04 to 1.22) 0.002* 0.98 (0.95 to 1.00) 0.074
*Significant at p<0.05.
†Variable was log10-transformed prior to analysis, so the coefficient represents the OR for a 10-fold increase in disease duration.
BP, blood pressure; DM, diabetes mellitus; HbA1c, glycated haemoglobin; SIMD, Scottish Index of Multiple Deprivation.
Figure 1 Kaplan-Meier survival curve of freedom from
retinopathy in patients with type 1 DM. DM, diabetes mellitus;
SIMD, Scottish Index of Multiple Deprivation.
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cohort, socioeconomic deprivation was associated with
sight-threatening DR, but not with non-sight-threatening
DR.17 Similarly, in Avon and Somerset, patients with
lower education levels were more likely to develop DR
than those with higher education.18 However, in a
Southampton cohort, Litwin et al found no association
between relative afﬂuence of residence and presence of
retinopathy at time of diagnosis of type 2 DM.19
From a European perspective, the EURODIAB IDDM
Complications study showed a higher prevalence of pro-
liferative DR in men with lower educational qualiﬁcations
compared with those with higher levels of education.20 In
Spain, socioeconomic status was not independently asso-
ciated with DR.21
Comparisons of development of retinopathy and socio-
economic deprivation between studies have to be care-
fully interpreted due to differences in measures of
deprivation. Data compiled from self-reported question-
naires on income and educational attainment may have
reporting biases.18 Moreover, most studies have only
looked at baseline or cross-sectional screening outcomes
and have not analysed these longitudinally over time.22 23
Meaning of the study
Eye healthcare in Scotland is provided free of charge,
and with the use of mobile screening units, socio-
economic deprivation is not independently associated
with increased prevalence of DR in type 2 DM. The lack
of association between socioeconomic deprivation and
DR in patients with type 2 DM in our study echoes the
ﬁndings in a study conducted by Guthrie et al.24 They
found that socioeconomic variations in the care of type
2 diabetes in Tayside have been largely eliminated under
the pay-for-performance scheme (Quality and Outcomes
Framework (QOF) 2004). However, younger patients
were less likely to receive systematic care and have
poorer control of intermediate outcomes. This is a
reﬂection of complexity in the management of diabetes,
which is beyond achieving ‘QOF targets’. Patient engage-
ment and health behaviours play an important role.
Indeed, the QOF was an effective instrument to incentiv-
ise care for older patients with type 2 DM, but its lack of
efﬁcacy in the control of DM in younger patients shows
that it is not a ‘one-size-ﬁts-all’ solution. This could be a
possible explanation to the observation that SIMD has a
signiﬁcant relationship with prevalence of retinopathy in
type 1 but not in type 2 DM.
It is worrying that despite free access to eye care in a
well-developed diabetes care system, there is still an
independent association between socioeconomic depriv-
ation and increased prevalence of DR in type 1 DM.
Whether socioeconomic deprivation is a cause or an
effect of DR in patient with type 1 DM remains unclear.
A possible explanation is that environmental factors
within deprived areas may trigger immune responses in
a genetically susceptible individual predisposed to type 1
DM and accelerate the development of complications.25
Another explanation could be a poorer control of dia-
betes in patients with lower socioeconomic background
—we have previously shown that missed appointments in
the diabetes retinal screening programme is associated
with younger patients living in more deprived areas.6 On
the other hand, the development of complications, such
as retinopathy, may impact on the socioeconomic status
Table 4 Retinopathy-free survival rates and HRs for type 1 DM according to the SIMD quintiles
Survival (retinopathy-free)
SIMD quintiles (%) (N) 1 year (%) 5 years (%) 10 years (%) HR (95% CI)*
0–20 most deprived 145 93.7 82.5 40.6 2.16 (1.27 to 3.69)
20–40 134 99.3 86.3 66.0 0.95 (0.52 to 1.74)
40–60 130 96.1 83.7 67.3 0.94 (0.51 to 1.72)
60–80 188 97.8 89.4 72.5 0.80 (0.45 to 1.43)
80–100 least deprived 112 98.1 86.4 66.7 –
*ORs are derived from a Cox regression model, which also accounts for age and gender, and are relative to the most deprived SIMD quintile.
SIMD quintile was significant in this model (p<0.001).
DM, diabetes mellitus; SIMD, Scottish Index of Multiple Deprivation.
Figure 2 Kaplan-Meier survival curve of freedom from
retinopathy in patients with type 2 DM. DM, diabetes mellitus;
SIMD, Scottish Index of Multiple Deprivation.
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of patients with type 1 DM. Poor diabetic control has
been known to negatively affect academic achievement
in school-aged children and reduce future career oppor-
tunities for patients with type 1 DM.26
Our study underscores the importance of targeted
interventions for those patients most at risk of developing
DR, in particular those with type 1 DM, and also the need
for better allocation of resources to tackle inequality in
eye healthcare. We need to ﬁnd innovative ways to engage
with our patients, especially with this younger age group,
and support local health authorities in setting priorities
for eye health initiatives to reduce inequalities.
Unanswered questions and future research
Future studies should focus on elucidating the complex
inter-relationship between socioeconomic deprivation,
environmental inﬂuences and development of retinop-
athy in type 1 DM. Furthermore, we need to identify
barriers to access health-seeking behaviours and unmet
needs in patients from poorer backgrounds. Eye health
equity proﬁles should be conducted within each locality,
as these are the key to understanding inherent health
inequalities within a distinct and unique community.
This will, ultimately, help to improve the delivery of
an effective multidisciplinary eye healthcare service.
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